DongKook Pharmaceutical (Korea) Today
| 086450 Stock | KRW 16,590 240.00 1.47% |
Performance1 of 100
| Odds Of DistressLess than 9
|
DongKook Pharmaceutical is trading at 16590.00 as of the 15th of December 2024, a 1.47 percent increase since the beginning of the trading day. The stock's open price was 16350.0. DongKook Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 21st of December 2023 and ending today, the 15th of December 2024. Click here to learn more.
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea. DongKook Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.. The company has 8.79 M outstanding shares. More on DongKook Pharmaceutical Co
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
DongKook Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. DongKook Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DongKook Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Heung Oh |
| Business Concentration | Health Care, Pharmaceuticals (View all Sectors) |
DongKook Pharmaceutical Co (086450) is traded on KOSDAQ in Korea and employs 1,056 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 145.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DongKook Pharmaceutical's market, we take the total number of its shares issued and multiply it by DongKook Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DongKook Pharmaceutical has 8.79 M outstanding shares.
DongKook Pharmaceutical Co has accumulated about 85.44 B in cash with 44.65 B of positive cash flow from operations.
Check DongKook Pharmaceutical Probability Of Bankruptcy
Ownership AllocationThe market capitalization of DongKook Pharmaceutical is W145.91 Billion. DongKook Pharmaceutical Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check DongKook Ownership Details
DongKook Pharmaceutical Risk Profiles
Although DongKook Pharmaceutical's alpha and beta are two of the key measurements used to evaluate DongKook Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.37 | |||
| Standard Deviation | 2.04 | |||
| Variance | 4.16 | |||
| Risk Adjusted Performance | 0.0033 |
DongKook Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in DongKook Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
DongKook Pharmaceutical Corporate Directors
Other Information on Investing in DongKook Stock
DongKook Pharmaceutical financial ratios help investors to determine whether DongKook Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DongKook with respect to the benefits of owning DongKook Pharmaceutical security.